Trial · NCT00569855
Intravenous Phenoxybenzamine Use in Pediatric Patients Undergoing Open-Heart Surgery
NCT00569855, Phase 2, Completed, University of Arkansas; results first posted 2011-03-01
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Intravenous Phenoxybenzamine Use in Pediatric Patients Undergoing Open-Heart Surgery. Trials, record NCT00569855. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00569855
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Intravenous Phenoxybenzamine Use in Pediatric Patients Undergoing Open-Heart Surgery
- NCT number
- NCT00569855
- Status
- Completed
- Phases
- Phase 2
- Enrollment
- 785 participants, actual
- Lead sponsor
- University of Arkansas
- Conditions
- Open-heart Surgery, Cardiopulmonary Bypass
- Interventions
- Phenoxybenzamine
- First posted
- 2007-12-10
- Last updated
- 2011-03-01
- Results first posted
- 2011-03-01
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of Participants Who Had Significant Hypotension as Defined in the Protocol as Need for Norepinephrine Dose >0.1mcq/kg/Min in the First 72 Hours Postoperatively | 72 hours postoperatively | Number of subjects who required Norepinephrine \>0.1mcq/kg/min |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number of Participants Who Had Significant Hypotension as Defined in the Protocol as Need for Norepinephrine Dose >0.1mcq/kg/Min in the First 72 Hours Postoperatively | 72 hours postoperatively | No. of subjects consented = 832; 785 subjects received study drug | participants | NUMBER |
Source ClinicalTrials.gov
Results by group1
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants Who Had Significant Hypotension as Defined in the Protocol as Need for Norepinephrine Dose >0.1mcq/kg/Min in the First 72 Hours Postoperatively | Subjects Who Received Study Drug | 25 | participants |
Source ClinicalTrials.gov
Participant flow3
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Subjects Who Received Study Drug | 785 | |
| Overall Study | COMPLETED | Subjects Who Received Study Drug | 785 | |
| Overall Study | NOT COMPLETED | Subjects Who Received Study Drug | 0 |
Source ClinicalTrials.gov
Adverse events1
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| serious | Early Death- defined as death within 72 hours of treatment with study drug | Surgical and medical procedures | Subjects Who Received Study Drug | 2 | 785 | 2 |
Source ClinicalTrials.gov
Adverse event totals3
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Subjects Who Received Study Drug | ||
| Total, other adverse events | Subjects Who Received Study Drug | 0 | 785 |
| Total, serious adverse events | Subjects Who Received Study Drug | 2 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00569855
GET https://conductscience.org/api/trials/v1/NCT00569855/registered